Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. (Q30381713)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. |
scientific article |
Statements
1 reference
Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. (English)
1 reference
François Roman
1 reference
Paul Gillard
1 reference
Mamadou Dramé
1 reference
Isabel Leroux-Roels
1 reference
Sheron Forgus
1 reference
Cathy Maes
1 reference
Fien De Boever
1 reference
Robbert van der Most
1 reference
Marcelle Van Mechelen
1 reference
Emmanuel Hanon
1 reference
14 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference